The ExTINGUISH Trial Methods Paper is available, Open Access! 👉There are no approved (or rigorously studied) treatments for NMDAR Encephalitis. 👉 Enrollment is ongoing for newly diagnosed NMDAR Encephalitis patients, via NIH/NINDS & the NeuroNEXT Clinical Trial Network

We've got an all-star team of experts lined up for TSF's Intermountain West Patient Day for Rare Neuroinflammatory Disorders in SLC on August 16th 🏔️ If you or your loved one are impacted by #NMOSD, #MOGAD, #AE or #SPS, join us! To register, visit tinyurl.com/TSFSLC

Patients and caregivers are welcome from the Mountain West and beyond. We are a quick 15 minutes from the SLC airport if you want to see beautiful Utah— including learning about our extensive outdoor accessibility options!— but please do first register below 👇

🏔 As we make final preparations for our Intermountain West Patient Day for Rare Neuroinflammatory Disorders in Salt Lake City tomorrow, we'd like to take a moment to recognize and thank Dr Stacey Clardy MD PhD and University of Utah Neurology, our partners and sponsors. We can't wait to see you!

Friends in high places 🏔️ Grateful to Stacey Clardy MD PhD, Ka-Ho, University of Utah Neurology and the @ExTINGUISHTrial for helping us make our Intermountain West Patient Day in Salt Lake City one of the most memorable and impactful ones yet! 🩷🧡💛

Utah patient day has been one of the most memorable and impactful patient days. Thank you to everyone that made it possible.🩷🧡💛

Neurology Podcast: Dr. Stacey Clardy and Dr. Walter Koroshetz discuss recent advancements in neurology, emerging genomic therapies, current NINDS priorities, and more in part one of this two-part series. Listen now: hubs.la/Q03Hr3F90 #NeuroX Stacey Clardy MD PhD Walter J. Koroshetz

🧠🎙️ Walter J. Koroshetz provides a comprehensive update - covering everything we need to know in 2025 - for all Neurology Clinicians & Neuroscience Researchers - Have a listen to this 2-part Neurology Journal podcast 👇 American Academy of Neurology Society for Neuroscience (SfN) American Neurological Association NeurologyMATCH2026 Association of University Professors of Neurology

🩷🧡💛 It’s been one month since our SLC Patient Day + we're still smiling! Read the summary, view the photo gallery and relive our most impactful day yet here: sumairafoundation.org/event-recap-sa… Thank you Stacey Clardy MD PhD, University of Utah Neurology and @ExTINGUISHTrial for your collaboration 🌺

At the #ECTRIMS2025 Pre-Day in Barcelona! Fascinating talk by Thaís Armangué on HSV encephalitis and NMDAR — a truly relevant and thought-provoking topic at the intersection of infection and autoimmunity.

"Stop staring at mountains. Climb them instead, yes, it's a harder process but it will lead you to a better view" Philipp Reiter No choice but to climb the mountain when recovering from Encephalitis… but there is an incredible community here to support you 🤝 @ExTINGUISHTrial

Still climbing. ⛰️ Still raising awareness. 🧠 Still enrolling in this critical clinical trial to bring patients with #NMDAR Encephalitis the evidence they so desperately need and deserve. 🤝 youtu.be/dIhD8y-hyPM?si…

ONLINE NOW: Anti-N-methyl-d-aspartate receptor encephalitis: insights and future treatment directions dlvr.it/TNXDzW

What if antibodies in autoimmune encephalitis could teach us how the brain works?🧬🧠 In anti-NMDAR encephalitis, immune attacks on NMDA receptors reveal their key role in memory, attention, and circuit reinforcement. Featured in Neurology Journal. #Neurology #NMDAR

🧠 New in Practical Neurology: Paraneoplastic KLHL11 antibody encephalitis presenting with progressive tinnitus, hearing loss, and cerebellar ataxia. KLHL11-IgG - strongly linked to testicular germ cell tumours - shows a distinctive “sparkles” pattern on immunofluorescence 🔬

Stacey Clardy MD PhD Read the related article in Neurology Open Access: neurology.org/doi/10.1212/WN…

Check out this article about the @ExTINGUISHtrial … and see if you detect anything unusual about the podcast “demo” on the article ??? 👂🎙️ NeurologyMATCH2026

NMDAR Encephalitis can happen any season, any time of year… which is why @ExTINGUISHTrial teams are always ready, on call, for all new NMDAR Encephalitis patients in the US, the Netherlands, and Spain.